Determination of the Absolute Configuration and a Practical Chiral Synthesis of 5-[5-(1-Methylethoxy)pyridin-2-yl]-5-methylimidazolidine-2,4-dione as a Novel Liver X Receptor -Selective Agonist

被引：2
|
作者：
Koura, Minoru [1 ]
Sumida, Hisashi [1 ]
Shibuya, Kimiyuki [1 ]
Ohba, Shigeru [2 ]
机构：
[1] Kowa Co Ltd, Tokyo New Drug Res Labs, Div Pharmaceut, 2-17-43 Noguchicho, Tokyo 1890022, Japan
[2] Keio Univ, Res & Educ Ctr Nat Sci, Kohoku Ku, Hiyoshi 4-1-1, Yokohama, Kanagawa 2238521, Japan
来源：
SYNTHESIS-STUTTGART | 2017年 / 49卷 / 09期
关键词：
liver X receptor; hydantoin; X-ray crystal structure analysis; chiral synthesis; optical resolution; d-(-)-mandelic acid; ENANTIOSELECTIVE STRECKER REACTION; LFA-1 ANTAGONIST BIRT-377; OPTICAL RESOLUTION; EFFICIENT SYNTHESIS; MANDELIC-ACID; AMINO-ACIDS; KETOIMINES; DERIVATIVES; CATALYST; RING;
D O I：
10.1055/s-0036-1588700
中图分类号：
O62 [有机化学];
学科分类号：
070303 ; 081704 ;
摘要：
We determined that the absolute configuration of 5-[5-(1-methylethoxy)pyridin-2-yl]-5-methylimidazolidine-2,4-dione (hydantoin) is the (S)-form for the liver X receptor (LXR) -selective agonist through X-ray crystal structure analysis of the hydantoin hydrogen bromide salt. Furthermore, we established a practical synthesis of the chiral hydantoin with 99% ee by the optical resolution of racemic methyl 2-amino-2-[5-(1-methylethoxy)pyridin-2-yl]propanoate with d-(-)-mandelic acid on a multi-kilogram scale. Finally, we improved the synthesis method of the LXR -selective agonist.
引用
收藏
页码：2074 / 2080
页数：7
相关论文
共 50 条
  • [21] Synthesis of the selective 5-hydroxytryptamine 4 (5-HT4) receptor agonist (+)-(S)-2-chloro-5-methoxy-4-[5-(2-piperidylmethyl)-1,2,4-oxadiazol-3-yl]aniline
    Suzuki, T
    Iwaoka, K
    Imanishi, N
    Nagakura, Y
    Miyata, K
    Nakahara, H
    Ohta, M
    Mase, T
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1999, 47 (01) : 120 - 122
  • [22] Synthesis and Biological Evaluation of N-(5-(pyridin-2-yl)-1,3,4-thiadiazol-2-yl)benzamide Derivatives as Lipoxygenase Inhibitor with Potential Anticancer Activity
    Aliabadi, Alireza
    Mohammadi-Farani, Ahmad
    Roodabeh, Sahar
    Ahmadi, Farahnaz
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2017, 16 (01): : 165 - 172
  • [23] Asymmetric synthesis of (-)-(4R, 5R)-4-[5-(benzo[1, 3]dioxo1-5-y1)-4-hydroxyl-1-(pyridin-2-yl)-4, 5-dihydro-1H-pyrazol-3-yl]benzamide
    Li, XZ
    Dai, MP
    Xiao, JH
    Li, S
    CHINESE CHEMICAL LETTERS, 2005, 16 (09) : 1137 - 1139
  • [24] Synthesis, crystal structure, and magnetic properties of binuclear cobalt(II) complex with 2-(5-{6-[5-(pyrazin-2-yl)-1H-1,2,4-triazol-3-yl]-pyridin-2-yl}-1H-1,2,4-triazol-3-yl)pyrazine
    Huang, X. Y.
    Jiang, Q. Q.
    Zhao, J. S.
    Zhang, S. C.
    Wang, J. L.
    RUSSIAN JOURNAL OF COORDINATION CHEMISTRY, 2015, 41 (03) : 202 - 206
  • [25] Synthesis, crystal structure, and magnetic properties of binuclear cobalt(II) complex with 2-(5-{6-[5-(pyrazin-2-yl)-1H-1,2,4-triazol-3-yl]-pyridin-2-yl}-1H-1,2,4-triazol-3-yl)pyrazine
    X. Y. Huang
    Q. Q. Jiang
    J. S. Zhao
    S. C. Zhang
    J. L. Wang
    Russian Journal of Coordination Chemistry, 2015, 41 : 202 - 206
  • [26] Synthesis and antimicrobial activity of novel 5-[(1H-indol-3-yl)methylene]thiazolidine-2,4-dione-[1,2,3]triazole hybrids
    Kamala, L.
    Veena, B. S.
    Lakshmi, P. V. Anantha
    Vasantha, P.
    Sujatha, E.
    RUSSIAN JOURNAL OF GENERAL CHEMISTRY, 2017, 87 (02) : 316 - 321
  • [27] Discovery of N-(2-benzyl-4-oxochroman-7-yl)-2-(5-(ethylsulfonyl) pyridin-2-yl) acetamide (b12) as a potent, selective, and orally available novel retinoic acid receptor-related orphan receptor γt inverse agonist
    Chen, Lei
    Su, Mei
    Jin, Qiu
    Wang, Chun-Gu
    Assani, Israa
    Wang, Mu-Xuan
    Zhao, Shi-Feng
    Lv, Shen-Min
    Wang, Jia-Wei
    Sun, Bo
    Li, Yan
    Liao, Zhi-Xin
    BIOORGANIC CHEMISTRY, 2022, 119
  • [28] Design, synthesis and biological evaluation of novel 5-((substituted quinolin-3-yl/1-naphthyl) methylene)-3-substituted imidazolidin-2,4-dione as HIV-1 fusion inhibitors
    Ibrahim, Tarek S.
    Bokhtia, Riham M.
    AL-Mahmoudy, Amany M. M.
    Taher, Ehab S.
    AlAwadh, Mohammed A.
    Elagawany, Mohamed
    Abdel-Aal, Eatedal H.
    Panda, Siva
    Gouda, Ahmed M.
    Asfour, Hany Z.
    Alhakamy, Nabil A.
    Youssif, Bahaa G. M.
    BIOORGANIC CHEMISTRY, 2020, 99
  • [29] A selective human H4-receptor agonist:: (-)-2-cyano-1-methyl-3-{(2R,5R)-5-[1H-imidazol-4(5)-yl]tetrahydrofuran-2-yl}methylguanidine
    Hashimoto, T
    Harusawa, S
    Araki, L
    Zuiderveld, OP
    Smit, MJ
    Imazu, T
    Takashima, S
    Yamamoto, Y
    Sakamoto, Y
    Kurihara, T
    Leurs, R
    Bakker, RA
    Yamatodani, A
    JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (14) : 3162 - 3165
  • [30] Absolute configuration from a redetermination of (+)-5-bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione at 118 (2) K
    Sledz, Pawel
    Chruszcz, Maksymilian
    Minor, Wladek
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2007, 63 : O4159 - U4050
12345